Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s disease: A Case Study From the NIH/NIA ADSP-AI/ML Consortium
Feixiong Cheng (Cleveland Clinic Genome Center, Cleveland Clinic), Yuan Hou (Cleveland Clinic Genome Center, Cleveland Clinic), Yichen Li (Cleveland Clinic Genome Center, Cleveland Clinic), Andrew A. Pieper (Case Western Reserve University), Jeffrey Cummings (University of Nevada Las Vegas)
Program Number/Abstract ID
Board 8057F
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.